The Sonic Healthcare Ltd (ASX: SHL) share price is in focus today after the company reported strong financial results for the year ended 30 June 2026, with revenue rising 13% to $10.87 billion and underlying net profit up 17% to $621 million.

What did Sonic Healthcare report?

• Revenue: $10,867 million, up 13% from FY2025
• Underlying EBITDA: $1,933 million, up 11%
• Underlying net profit after tax (NPAT): $621 million, up 17%
• Earnings per share: 125.6 cents, up 14%
• Total dividend: $1.08 per share (final dividend $0.63, franked to 60%)
• Strong organic revenue growth of 5%

What else do investors need to know?

Sonic Healthcare completed several strategic acquisitions during FY2026, including major German provider LADR and Cairo Diagnostics. The integration of these businesses is on track, with over 40% of expected synergies realised in year one for LADR. The company has also continued to sharpen its focus on advanced diagnostics, with standout growth in its genetics and specialist pathology businesses, both in Australia and internationally.

Management is investing in the digital and AI transformation of core systems. Around $30 million per year is earmarked over the next three years to modernise finance, supply chain and HR, supporting future productivity. Meanwhile, a $445 million sale and leaseback of its Brisbane hub laboratory strengthened Sonic Healthcare’s balance sheet and capital flexibility.

What’s next for Sonic Healthcare?

Looking ahead to FY2027, Sonic Healthcare expects continued organic growth across its major markets, underpinned by demand for personalised and preventative healthcare. The company has provided EBITDA guidance in the range of $1,950 million to $2,030 million (constant currency), excluding costs from its IT transformation program. Some earnings headwinds are anticipated from regulatory changes in Switzerland and a slower ramp-up of profit from its large UK NHS contract.

The group intends to continue progressing US operational improvements, realise further synergy benefits from its recent acquisitions, and optimise costs through automation and strategic procurement.

Sonic Healthcare share price snapshot

It has been a tough 12 months for the Sonic Healthcare share price. During this time, the company’s shares have underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of 18%.

View Original Announcement

The post Sonic Healthcare share price in focus on FY26 profit jump and digital push appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Sonic Healthcare, AMP, CBA shares
• 8 ASX 200 shares with fresh buy ratings this week
• Why this ASX healthcare stock is a top rebound candidate with big upside 
• How much superannuation is needed to target $8,000 per month in passive income?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Ridley Corporation Ltd (ASX: RIC) share price is in focus after the company reported underlying EBITDA jumped 61.8% to $157.8 million, and a 100% franked final dividend of 5.35 cents per share, for the year ended 30 June 2026.

What did Ridley report?

• Underlying EBITDA: $157.8 million, up 61.8% from $97.5 million in the prior corresponding period
• Underlying NPAT: $61.0 million, up 41.5% year on year
• Final dividend: 5.35 cps, fully franked (up from 5.00 cps in FY25)
• Operating cash flow: $122.4 million, up from $68.3 million last year
• Leverage: 0.85x (target range: 1–2x)
• Statutory NPAT: $27.6 million (after significant items)

What else do investors need to know?

Ridley completed the acquisition of Incitec Pivot Fertilisers during the year, driving a step-change in earnings and expanding its position in the Australian agricultural sector. The business now holds number one positions across fertilisers, bulk stockfeeds, and packaged feeds and ingredients.

Fertilisers contributed EBITDA of $72.2 million over nine months, meeting the higher end of expectations, while Bulk Stockfeeds and Packaged Feeds saw growth in volumes, though operational constraints temporarily affected ingredients performance.

The company maintained a solid balance sheet, with headline leverage below the 1–2x target, despite the fertiliser acquisition. Ridley’s cash generation improved, supporting a progressive dividend and ongoing investment.

What’s next for Ridley?

Ridley expects earnings growth from each division in FY27 as it continues integrating its fertilisers business, expands capacity in bulk stockfeeds, and aims for operational recovery in packaged feeds and ingredients.

Management intends to stick with its capital allocation framework and maintain a dividend payout between 50–70% of NPAT. Investment remains focused on efficiency, network upgrades, and pursuing disciplined growth opportunities. The company sees its diversified position providing resilience through changing agricultural cycles and external challenges.

Ridley share price snapshot

Over the past 12 months, Ridley shares have risen 3%, slightly outperforming the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Ridley: FY26 profit jumps on fertiliser boost appeared first on The Motley Fool Australia.

More reading

• MA Financial delivers record 1H26 earnings and lifts dividend
• Sonic Healthcare share price in focus on FY26 profit jump and digital push
• IPH Ltd FY26 earnings: resilient profit growth and higher dividend
• 2 ASX shares tipped to grow 40% or more in the next 12 months
• Have these ASX 200 shares now fallen too far to ignore the value?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The IPH Ltd (ASX: IPH) share price is in focus after the company reported a resilient FY26 result, with net profit after tax rising 16.9% to $80.4 million and total dividends up 5.5% to 38.5 cents per share.

What did IPH Limited report?

• Revenue rose 0.6% to $710.4 million
• Net profit after tax increased 16.9% to $80.4 million
• Underlying EBITDA of $205.9 million, down 0.6%
• Final dividend of 19.5 cents per share (30% franked), total FY26 dividend 38.5 cps
• Net tangible asset per share of $(0.94)
• Share buy-back: 5.4 million shares repurchased for $18.7 million

What else do investors need to know?

During the year, IPH continued to execute its strategy of organic growth, disciplined cost control, and investment in technology— including a stronger push into AI and digital platforms. The integration of Pizzeys and Applied Marks into Griffith Hack from 1 July 2026 is set to enhance service capability and scale for Australian clients.

IPH’s international diversification helped balance market challenges, with Canada delivering strong growth despite some delays in the Canadian Intellectual Property Office system, and Asia returning to revenue growth on a constant currency basis. The Australia/New Zealand segment remained soft due to lower US-originated patent work.

What did IPH Ltd management say?

IPH’s outgoing CEO and Managing Director, Dr Andrew Blattman, said:

As I reflect on my final year as Managing Director and CEO of IPH, I do so with a strong sense of pride in the business we have built together. It has been a remarkable journey from our origins as a single firm in Australia to the leading intellectual property services group we are today, operating across Australia, New Zealand, Asia and Canada and serving clients around the world.

What’s next for IPH Ltd?

Looking to FY27, IPH plans to focus on operational improvement and technology investment, including greater adoption of AI tools to improve efficiency and enhance service delivery. The group is also updating its dividend payout policy to a 70–90% range of statutory EPSA, offering more flexibility for future dividends.

Future strategy continues to emphasise strengthening international client relationships, growing work referred from the US, Europe, China, Japan and Korea, and supporting staff development across its global network. Management is confident IPH’s diversified revenue base and international reach position it well for long-term, sustainable growth.

IPH Ltd share price snapshot

Over the past 12 months, the IPH share price has underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of 25%.

View Original Announcement

The post IPH Ltd FY26 earnings: resilient profit growth and higher dividend appeared first on The Motley Fool Australia.

More reading

• How much passive income can I earn off my $730,000 superannuation balance?
• How much passive income could I earn from a $500,000 superannuation balance?
• Rotating into dividend shares? 3 of your best options right now with yields as high as 9%
• 2 ASX dividend shares I’d buy for passive income right now
• How much superannuation is needed to target a $100,000 annual passive income?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended IPH Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.